Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

SEHK:874 Stock Report

Market Cap: HK$47.5b

Guangzhou Baiyunshan Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

SEHK:874 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Nov 24SellHK$6,282,270Norges Bank Investment ManagementCompany348,000HK$18.05
20 Nov 24SellHK$5,295,391Norges Bank Investment ManagementCompany292,000HK$18.13
14 Nov 24SellHK$12,159,166Norges Bank Investment ManagementCompany664,000HK$18.31
08 Nov 24SellHK$10,322,695Norges Bank Investment ManagementCompany540,000HK$19.12
01 Nov 24SellHK$14,836,095Norges Bank Investment ManagementCompany808,000HK$18.36
29 Oct 24SellHK$7,582,070Norges Bank Investment ManagementCompany404,000HK$18.77
23 Oct 24SellHK$15,310,540Norges Bank Investment ManagementCompany794,000HK$19.28
17 Oct 24SellHK$11,659,005Norges Bank Investment ManagementCompany618,000HK$18.87
14 Oct 24SellHK$12,960,174Norges Bank Investment ManagementCompany662,000HK$19.58
09 Oct 24SellHK$36,989,058Norges Bank Investment ManagementCompany1,680,000HK$22.02
04 Oct 24SellHK$10,693,500Norges Bank Investment ManagementCompany506,000HK$21.13
30 Sep 24SellHK$3,836,009Norges Bank Investment ManagementCompany186,000HK$20.62

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 874?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,3000.000141%
Institutions311,504,25319.2%
General Public564,711,34134.7%
Private Companies749,573,05546.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 63.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45%
Guangzhou Pharmaceutical Holdings Limited
732,305,103HK$21.4b0%no data
4.16%
Guangzhou China Life Insurance Urban Development Industry Investment Enterprises (LP)
67,576,183HK$2.0b0%87.43%
2.91%
China Securities Finance Corp, Asset Management Arm
47,277,962HK$1.4b0%0.22%
2.09%
Norges Bank Investment Management
33,955,879HK$991.5m-41.7%0.01%
1.22%
E Fund Management Co., Ltd.
19,853,370HK$579.7m95.7%0.09%
1.06%
Guangzhou Industrial Investment and Capital Operation Holding Group Ltd.
17,267,952HK$504.2m0%no data
0.81%
LSV Asset Management
13,186,111HK$385.0m0%0.06%
0.81%
Huatai-PineBridge Fund Management Co., Ltd.
13,118,792HK$383.1m457%0.12%
0.77%
The Vanguard Group, Inc.
12,577,308HK$367.2m0.27%no data
0.54%
China Asset Management Co. Ltd.
8,795,136HK$256.8m0%0.04%
0.53%
Zhong Ou Fund Management Co., Ltd
8,680,636HK$253.5m0%0.13%
0.53%
Bosera Asset Management Co., Ltd.
8,662,836HK$252.9m0%0.15%
0.53%
Dacheng Fund Management Co., Ltd.
8,657,836HK$252.8m0%0.21%
0.38%
Harvest Fund Management Co. Ltd.
6,245,852HK$182.4m0%0.05%
0.32%
China Universal Asset Management Company Ltd.
5,247,676HK$153.2m0%0.07%
0.3%
Dimensional Fund Advisors LP
4,806,604HK$140.3m0.5%no data
0.28%
First Seafront Fund Management Co., Ltd
4,613,600HK$134.7m0%0.22%
0.28%
BlackRock, Inc.
4,509,887HK$131.7m-15.8%no data
0.23%
China Merchants Fund Management Company Ltd.
3,718,630HK$108.6m0%0.05%
0.21%
Zhongrong Fund Management Co., Ltd.
3,399,300HK$99.3m0%1.1%
0.2%
Hongde Fund Management Co., Ltd.
3,332,152HK$97.3m0%0.3%
0.2%
Fullgoal Fund Management Co. Ltd.
3,222,303HK$94.1m0%0.03%
0.16%
GF Fund Management Co., Ltd.
2,673,013HK$78.0m0%0.02%
0.12%
Tianhong Asset Management Co., Ltd.
1,923,907HK$56.2m0%0.04%
0.09%
Penghua Fund Management Co., Ltd.
1,461,029HK$42.7m-6.46%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:50
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is covered by 29 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhi Xue DiaoAvic Securities Co., Ltd
null nullBOCI Research Ltd.
Feng Qiang SunBOCOM International Securities Limited